Acquisitions, Dispositions and Other Transactions (Details) (USD $)	0 Months Ended	3 Months Ended						12 Months Ended
	Mar. 31, 2013	Mar. 31, 2013		Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Mar. 31, 2013	Mar. 18, 2013
Basic and diluted loss per share:
Weighted average common shares outstanding (in shares)		487,712,326	[1]				438,086,034
Gross sales		$ 4,172,334	[1]				$ 238,674
TLC
Acquisitions
Ownership interest acquired of the voting stock (as a percent)									64.60%
Ownership interest acquired of all the stock (as a percent)									51.70%
Value of convertible note									6,500,000
Value of promissory note									4,000,000
Acquisition related costs		138,000		338,000
Current assets:
Cash and cash equivalents									84,062
Accounts receivable									259,602
Inventory									19,892,740
Prepaid expenses and other									1,074,420
Total current assets									21,310,824
Property, plant and equipment	3,400,000	3,400,000						3,400,000	28,469,390
Other assets									3,946,570
Total assets									53,726,784
Current liabilities:
Accounts payable - trade									6,383,107
Line of credit payable									9,319,612
Customer advanced payments									4,132,386
Current portion of long-term debt									354,390
Other current liabilities									3,962,045
Total current liabilities									24,151,540
Long-term debt									9,265,766
Total liabilities									33,417,306
Stockholders' equity:
Stockholders' equity attributable to CVSL									10,500,000
Stockholders' equity attributable to noncontrolling interest									9,809,478
Total stockholders' equity									20,309,478
Total liabilities and stockholders' equity									53,726,784
TLC Results from Operations
Gross sales	3,902,854
Program costs and discounts	(1,524,624)
Net sales	2,378,230
Costs of sales	1,340,229
Gross profit	1,038,001
Selling, general and administrative	951,972
Operating profit	86,029
Interest expense, net	37,488
Net income	48,541
Net earnings attributable to noncontrolling interest	23,445
Net earnings attributed to CVSL	25,096
Pro forma Results
Gross sales		20,141,952					24,002,207
Gross profit		5,133,580					4,519,011
Operating loss		(3,662,865)					(3,260,583)
Net loss		(4,149,395)					(4,140,433)
Net loss attributed to CVSL		(2,796,906)					(2,135,269)
Basic and diluted loss per share:
Weighted average common shares outstanding (in shares)		487,712,326					438,086,034
Net loss per share attributable to CVSL (in dollars per share)		$ (0.01)
Gross sales		$ 19,900,000		$ 36,800,000	$ 26,900,000	$ 25,400,000		$ 109,000,000

[1] Includes a full quarter of CVSL and HCG but only 13 days of results for TLC. Please see footnote (2).